This article was originally published on PharmaTimes http://www.pharmatimes.com/news/ema_approves_flutiform_for_children_with_asthma_1274699

The European Medicines Agency (EMA) has approved Flutiform pMDI for use in the treatment of children with asthma aged five years and over.

Related Posts